{
    "N/R/U": null,
    "Applicant": "ThromboGenics Inc.",
    "BLA Number": "125422",
    "Proprietary Name": "Jetrea",
    "Proper Name": "ocriplasmin",
    "BLA Type": "351(a)",
    "Strength": "0.375MG/0.3ML (1.25MG/ML)",
    "Dosage Form": "Injection ",
    "Route of Administration": "Intravitreal",
    "Product Presentation": "Single-Dose Vial",
    "Marketing Status": "Disc",
    "Licensure": "Voluntarily Revoked",
    "Approval Date": "February 22, 2017",
    "Ref. Product Proper Name": null,
    "Ref. Product Proprietary Name": null,
    "Supplement Number": "38",
    "Submission Type": "Supplement",
    "License Number": "1866",
    "Product Number": "001",
    "Center": "CDER",
    "Date of First Licensure": null,
    "Exclusivity Expiration Date": null,
    "First Interchangeable Exclusivity Exp. Date": null,
    "Ref. Product Exclusivity Exp. Date": null,
    "Orphan Exclusivity Exp. Date": null
}